Pursuant to clause 30 of the COVID-19 Public Health Response (Air Border) Order 2021 (“Order”), I, Dr Ashley Bloomfield, Director-General of Health, hereby specify the following to be appropriate evidence for the purposes of clause 30 of the Order.
- All COVID-19 test results (required to satisfy the negative COVID-19 test requirement) must contain the following information:
- full name of person tested
- date of birth of person tested and/or the passport number of the person tested
- if the COVID-19 test was testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid using polymerase chain reaction (PCR test), the name of the laboratory at which the PCR test was processed
- if the COVID-19 test was testing for antigens specific to SARS-CoV-2 (rapid antigen test or RAT) or testing for SARS-CoV-2 viral ribonucleic acid using loop-mediated isothermal amplification (LAMP), the name of the health professional that supervised the test
- written confirmation of:
- the date on which the COVID-19 test was conducted; and
- the time the COVID-19 test was conducted to establish that the COVID-19 test as undertaken within the 48-hour period for the PCR test or 24 hour period for the RAT or LAMP prior to the person’s direct flight or connecting flight
- written confirmation from the laboratory (for PCR test) or health professional of the type of test that was conducted.
- The evidence may be in paper or digital form.
- The evidence must include either:
- the supervisor’s letterhead; or
- a stamp that confirms the supervisor’s name, occupation, and employer.
- The evidence must be in English, or accompanied by a certified translation into English.
- The evidence of a COVID-19 test result for persons arriving from a Group 3 place (as set out in schedule 2 of the Order) must be by a laboratory authorised to perform testing for COVID-19 by the government in the country in which the test is administered.
This notice will come into force at 11.59pm on 6 March 2022.
Dated at Wellington this 2nd day of March 2022.
Dr ASHLEY BLOOMFIELD, Director-General of Health.